Boys Arnold & Co. Inc. Buys Shares of 1,707 Monsanto Company (MON)

Boys Arnold & Co. Inc. bought a new position in shares of Monsanto Company (NYSE:MON) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,707 shares of the basic materials company’s stock, valued at approximately $202,000.

Several other large investors have also added to or reduced their stakes in MON. Acrospire Investment Management LLC bought a new stake in shares of Monsanto during the first quarter worth $113,000. Pinnacle Financial Partners Inc. bought a new stake in shares of Monsanto in the second quarter valued at about $114,000. JNBA Financial Advisors raised its holdings in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after acquiring an additional 45 shares in the last quarter. Armbruster Capital Management Inc. raised its holdings in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after acquiring an additional 125 shares in the last quarter. Finally, Penserra Capital Management LLC raised its holdings in shares of Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after acquiring an additional 112 shares in the last quarter. Institutional investors and hedge funds own 74.79% of the company’s stock.

In other Monsanto news, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.

Shares of Monsanto Company (NYSE:MON) traded up 0.336% on Friday, hitting $117.995. The stock had a trading volume of 998,254 shares. The firm’s 50-day moving average is $117.23 and its 200-day moving average is $116.41. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The company has a market cap of $51.84 billion, a price-to-earnings ratio of 25.485 and a beta of 1.07.

Monsanto (NYSE:MON) last released its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period last year, the business earned $2.17 earnings per share. On average, analysts expect that Monsanto Company will post $4.89 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio is 46.75%.

A number of brokerages have commented on MON. UBS AG downgraded shares of Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target on the stock in a research note on Thursday. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Piper Jaffray Companies set a $128.00 price target on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Finally, Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research note on Tuesday, June 27th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $123.49.

WARNING: “Boys Arnold & Co. Inc. Buys Shares of 1,707 Monsanto Company (MON)” was first published by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this article can be read at https://baseballnewssource.com/markets/1707-shares-in-monsanto-company-mon-purchased-by-boys-arnold-co-inc/1603080.html.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.

 


Latest News

Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game


Leave a Reply

 
© 2006-2017 BBNS.